VitaNova Life Sciences Corp
Close on Oct 19, 2026
- Market cap
- $37.52M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
VitaNova Life Sciences has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements VitaNova Life Sciences filed with the SEC
CURRENT REPORT
Event dated Mar 12, 2026, from SEC EDGAR
CURRENT REPORT
Event dated Feb 19, 2026, from SEC EDGAR
CURRENT REPORT
Event dated Jan 27, 2026, from SEC EDGAR
FORM 8-K
Event dated Jan 9, 2026, from SEC EDGAR
FORM 8-K
Event dated Oct 7, 2025, from SEC EDGAR
CURRENT REPORT
Event dated Jun 5, 2024, from SEC EDGAR
CURRENT REPORT
Event dated Jan 30, 2024, from SEC EDGAR
FORM 8-K
Event dated Jan 8, 2024, from SEC EDGAR
FORM 8-K
Event dated Sep 12, 2023, from SEC EDGAR
CURRENT REPORT
Event dated Jun 14, 2023, from SEC EDGAR
FORM 8-K
Event dated Jul 31, 2021, from SEC EDGAR
YJGJ FORM 8-K ITEMS 4.01 AND 9.01
Event dated Nov 30, 2021, from SEC EDGAR
Current report on Form 8-K
Event dated Jul 28, 2021, from SEC EDGAR
CURRENT REPORT
Event dated Jun 9, 2021, from SEC EDGAR
FORM 8-K
Event dated May 25, 2021, from SEC EDGAR